For CLTI patients with infrapopliteal artery disease, everolimus-eluting scaffold was found to be superior to angioplasty.

Published Date: 08 Nov 2023

In comparison to angioplasty, everolimus-eluting resorbable scaffold treatment produces better results for chronic conditions, according to a multi-institution study headed by the Prince of Wales Hospital and University of New South Wales, Australia.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Boom in ADHD Coaching Has Few Rules

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot